Yaride Pérez Pacheco

Dr. Yaride Pérez Pacheco

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2025 in Molecules
Verified
Journal Article
Open access
PDF file
YPYaride Pérez Pacheco
Yaride Pérez Pacheco
Bartosz TylkowskiBartosz Tylkowski
Bartosz Tylkowski
Ricard Garcia-VallsRicard Garcia-Valls
Ricard Garcia-Valls
PH sensitivity of chitosan allows for precise phase transitions in acidic environments, controlling swelling and shrinking, making chitosan suitable for drug delivery systems. pH transitions are modulated by the presence of cross-linkers by the functionalization of the chitosan chain. This review relays a summary of chitosan functionalization and tailoring to optimize drug release. The potential to customize chitosan for different environments and therapeutic uses introduces opportunities for drug encapsulation and release. The focus on improving drug encapsulation and sustained release in specific tissues is an advanced interpretation, reflecting the evolving role of chitosan in achieving targeted and more efficient therapeutic outcomes. This review describes strategies to improve solubility and stability and ensure the controlled release of encapsulated drugs. The discussion on optimizing factors like cross-linking density, particle size, and pH for controlled drug release introduces a deeper understanding of how to achieve specific therapeutic effects. These strategies represent a refined approach to designing chitosan-based systems, pushing the boundaries of sustained release technologies and offering new avenues for precise drug delivery profiles.

24 January 2017 in Journal of Physics: Conference Series
Verified
Conference Paper
Open access
PDF file
MHM Hasani
M Hasani
AKA Khodadadi
A Khodadadi
SKS M J Koleini
S M J Koleini
ASA H Saeedi
A H Saeedi
YPYaride Pérez Pacheco
Yaride Pérez Pacheco
AMAngel M Meléndez
Angel M Meléndez
Bimetallic Pd-Au nanocluster arrays grown on nanostructured

Verified
Journal Article
Open access
PDF file
YPYaride Pérez Pacheco
Yaride Pérez Pacheco
DPDeepak Parajuli
Deepak Parajuli
Ricard Garcia-VallsRicard Garcia-Valls
Ricard Garcia-Valls
Chronic diseases such as cancer, cardiovascular disorders, neurodegenerative conditions, chronic respiratory diseases, autoimmune disorders, chronic kidney disease, persistent infectious diseases, diabetes, and ocular inflammation remain leading causes of morbidity and mortality worldwide. Their complex pathophysiologies and the limitations of conventional therapies underscore the urgent need for advanced drug delivery platforms that enhance therapeutic efficacy while minimizing off-target effects and systemic toxicity leading to adverse reactions. Nanomedicine has emerged as a transformative approach, with chitosan-based nanocarriers offering advantages due to their biocompatibility, biodegradability, mucoadhesive properties, and ability to be physic-chemically modified. These nanocarriers improve solubility, stability, bioavailability, and the therapeutic index of drugs, while enabling controlled release, targeted delivery, and immune modulation. This review highlights recent advances in chitosan-based nanomedicine for the management of chronic disease. We discuss methods of synthesis such as ionic gelation and electrospray, functionalization approaches, and immunomodulatory roles that expand therapeutic potential. The evidence emphasizes that chitosan nanocarriers are a versatile, safe, and effective platform which can be used to improve clinical results, reduce adverse effects, and advance the science of personalized medicine.

28 February 2024 in Afinidad. Journal of Chemical Engineering Theoretical and Applied Chemistry
Verified
Journal Article
Closed access
YPYaride Pérez Pacheco
Yaride Pérez Pacheco
TATiziano Alimandi
Tiziano Alimandi
Bartosz TylkowskiBartosz Tylkowski
Bartosz Tylkowski
MSMiquel Sisteré
Miquel Sisteré
RGRicard García-Valls
Ricard García-Valls

29 January 2020
Verified
Conference Paper
Closed access
YPYaride Pérez Pacheco
Yaride Pérez Pacheco
RGRicard García-Valls
Ricard García-Valls
Bartosz TylkowskiBartosz Tylkowski
Bartosz Tylkowski
MSMiquel Sisteré
Miquel Sisteré

1 February 2023
Verified
Conference Paper
Closed access
YPYaride Pérez Pacheco
Yaride Pérez Pacheco
TATiziano Alimandi
Tiziano Alimandi
Bartosz TylkowskiBartosz Tylkowski
Bartosz Tylkowski
MSMiquel Sisteré
Miquel Sisteré
RGRicard García-Valls
Ricard García-Valls